LIGAND PHARMACEUTICALS (LGND)

US53220K5048 - Common Stock

70.57  +0.2 (+0.28%)

After market: 70.57 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
131.31M196.20M277.10M186.40M120.30M
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
10.51M52.80M62.20M30.40M11.30M
Gross Profit
120.80M143.40M215.00M156.00M108.90M
Operating Expenses
110.98M140.40M136.00M147.30M114.70M
Research and Development
24.54M36.10M69.00M59.40M55.90M
Selling, General, and Administrative Expenses
52.79M70.10M57.50M64.40M41.90M
Operating Income
9.82M3.00M78.90M8.70M-5.70M
Interest Income/Expense
53.67M28.80M-22.70M-36.30M-4.40M
Other Income/Expense
-1.95M0.00-1.60M-100.00K-6.00M
Non Recurring Items
2.12M4.20M-7.30M17.10M812.80M
Income Before Taxes
63.66M36.00M47.30M-10.50M796.60M
Income Tax
9.84M41.20M-9.80M-7.60M167.30M
Net Income
52.15M-33.40M57.10M-3.00M629.30M
EBITDA
46.34M54.50M130.00M34.40M12.70M
 
Per Share Data
EPS Diluted Total Ops
2.93-1.973.31-0.1831.78
Non GAAP EPS
6.104.286.424.553.04
 
Statistics
Gross Profit Margin
91.99%73.09%77.59%83.69%90.52%
Profit Margin
39.72%-17.02%20.61%-1.61%523.11%
Operating Profit Margin
7.48%1.53%28.47%4.67%-4.74%

All data in USD

Charts